Search by Drug Name or NDC

NDC 47335-0767-88 Paliperidone 9 mg/1 Details

Paliperidone 9 mg/1

Paliperidone is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is PALIPERIDONE.

MedlinePlus Drug Summary

Paliperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Paliperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 47335-0767-88
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Paliperidone

Product Information

NDC	47335-0767
Product ID	47335-767_3cd6c22e-945d-4231-9c3c-9a728868b442
Associated GPIs	59070050007530
GCN Sequence Number	061987
GCN Sequence Number Description	paliperidone TAB ER 24 9 MG ORAL
HIC3	H7T
HIC3 Description	ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
GCN	97771
HICL Sequence Number	034343
HICL Sequence Number Description	PALIPERIDONE
Brand/Generic	Generic
Proprietary Name	Paliperidone
Proprietary Name Suffix	n/a
Non-Proprietary Name	Paliperidone
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	9
Active Ingredient Units	mg/1
Substance Name	PALIPERIDONE
Labeler Name	Sun Pharmaceutical Industries, Inc.
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA205618
Listing Certified Through	2024-12-31

Package

NDC 47335-0767-88 (47335076788)

Pricing Information	N/A
NDC Package Code	47335-767-88
Billing NDC	47335076788
Package	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-767-88)
Marketing Start Date	2018-08-01
NDC Exclude Flag	N